From April 1, 2023 to June 30, 2023, the company has repurchased 6,482,035 shares, representing 1.12% for CNY 122.21 million. With this, the company has completed the repurchase of 9,835,793 shares, representing 1.7% for CNY 199.51 million under the buyback announced on October 21, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
20.14 CNY | -2.23% | -1.56% | +3.02% |
04-26 | Sansure Biotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
02-29 | Sansure Biotech's 2023 Profit Drops 81% as Revenue Slumps 84% | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+3.02% | 1.64B | |
-3.58% | 12.64B | |
-1.48% | 8.46B | |
+8.70% | 5.66B | |
+24.40% | 5.27B | |
-4.58% | 4.49B | |
-52.23% | 3.11B | |
+16.25% | 2.87B | |
+31.56% | 2.31B | |
-4.08% | 1.89B |
- Stock Market
- Equities
- 688289 Stock
- News Sansure Biotech Inc.
- Tranche Update on Sansure Biotech Inc.'s Equity Buyback Plan announced on October 21, 2022.